Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010485

CHIEF FINANCIAL OFFICER gave up 1,303 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 2,694 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-07 Option exercise +2,694 27,801 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-07 Shares withheld for taxes −1,303 $20.28 $26,425 26,498 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-07 Option exercise · Restricted Share Unit −2,694 2,694 D
Loading xslF345X05/form4-04092025_080402.xml…